Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Diagnostics of Hepatocellular Carcinoma in Patients With Liver Cirrhosis by Novel Molecular Spectrometric Biomarkers in Blood Plasma

NCT04221347 is registered in ClinicalTrials.gov with Military University Hospital, Prague as lead sponsor.

NCT NCT04221347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04221347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Diagnostics of Hepatocellular Carcinoma in Patients With Liver Cirrhosis by Novel Molecular Spectrometric Biomarkers in Blood Plasma
Lead sponsor
Military University Hospital, Prague
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2017
Completion date
December 31, 2022
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, liver, hepatocellular carcinoma, liver cancer